First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US

The experimental vaccine, developed by Moderna and the National Institute of Allergy and Infectious Diseases, began Phase 3 trials on Monday.